Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-19-030603

Chief Financial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BLOCH KATHLEEN P. Chief Financial Officer 2019-06-07 Option exercise +10,000 $5.60 $56,000 252,725 D
Derivatives
BLOCH KATHLEEN P. Chief Financial Officer 2019-06-07 Option exercise · Stock Option (right to buy) −10,000 65,650 D
Loading xslF345X03/tv523397_4.xml…